Oxytocin and real-time fMRI neurofeedback of the anterior insula
Official title: Effects of Intransal Oxytocin on Real-time fMRI Neurofeedback Training of Anterior Insula Activity Using an Interoceptive Strategy
Run by University of Electronic Science and Technology of China · NCT07559656 · Data updated 2026-11-12
This trial will test whether a single intranasal dose of oxytocin helps healthy men use interoceptive strategies to improve real-time fMRI neurofeedback targeting the anterior insula.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 30 Years |
| Sex | Men only |
| Enrollment | 80 (estimated) |
| Sponsor | University of Electronic Science and Technology of China Academic / other |
| Locations | 1 site (Chengdu, Sichuan) |
| Status | Recruiting |
| Started | April 26, 2026 |
| Main results expected | September 27, 2026 |
| Study ends | October 1, 2026 |
| Registry record updated | April 30, 2026 |
| Trial ID | NCT07559656 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy adult men without current or past psychiatric or neurological disorders who can safely undergo MRI and are willing to self-administer intranasal spray.
✕Probably not a fit
People with a history of brain injury, psychiatric or neurological illness, MRI contraindications, or women (who were not included) are unlikely to benefit from the findings of this specific trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blind, placebo-controlled study enrolls 80 healthy male participants who self-administer either 24 IU intranasal oxytocin or placebo. All participants receive continuous real-time fMRI neurofeedback from the left anterior insula across four training sessions and one transfer session without feedback. Behavioral effects are measured with pain-empathy ratings after each block and interoceptive accuracy is measured with a heartbeat detection/counting task before and after training. Personality and interoception-related traits are assessed with validated questionnaires to explore individual differences in neurofeedback response.
Why it matters
Potential benefit: If successful, the approach could make it easier for people to learn to regulate anterior insula activity with neurofeedback, informing methods to enhance interoception and empathy-related brain function.
How similar studies have gone: Prior studies show oxytocin can alter social and interoceptive processing and separate rt-fMRI neurofeedback studies can change insula activity, but combining oxytocin with neurofeedback is novel with limited prior direct evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy subjects without any past or present psychiatric or neurological disorders. Exclusion Criteria: * History of brain injury medical or mental illness. * Contraindication to MRI scanning (e.g., metal implants, claustrophobia or other --conditions that make them inappropriate for MRI scanning).
Where it's running
-
University of Electronic Science and Technology of China
Chengdu, Sichuan, China Recruiting
Study contacts
- Study coordinator: Shuxia Yao, Dr
- Email: yaoshuxia@uestc.edu.cn
- Phone: 18111297596
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Do Quercefit® or Ubiqsome™ help with aging and metabolic health in adults 50–75?
This study tests whether Quercefit® or Ubiqsome™ can improve aging markers, blood sugar, and heart health in sedentary adults aged 50–75 compared with a placebo.
-
NVTIA Ergothioneine for Healthy Aging and Skin Health
This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.
-
Miricell supplementation and markers of healthy aging
This trial tests whether taking Miricell once daily for 12 weeks improves cellular health and brain/metabolic indicators in adults aged 40–70 compared with a placebo.
-
Does daily lean beef support brain health in older adults
In healthy adults aged 65 and up, this study tests whether eating lean beef every day for two weeks can influence brain health markers compared with a non-beef, protein-matched option.
-
Adaptive computerized training to boost thinking in healthy seniors and those with mild cognitive impairment
This study tests whether a computer-based training program can improve executive thinking in older adults, including those with mild cognitive impairment, and see if it also helps memory and well-being.
-
SHARP: Personalized Health and Behavior Plan to Lower Biological Age in Older Adults
A 12-month randomized trial tests whether a personalized health and behavior program can lower biological age and improve function in healthy adults over 50.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.